Ken: And if you're interested in this integration between OmniPlan and OmniFocus, please send email to omniplan@omnigroup.com, and just let us know, and that way we can add you to a list and tell you specifically when those builds are ready for testing.
Omniplan For Academics
Mikell Taylor:I do. It was in, I believe, 2008. I had just become a militant Mac user for the first time. This was when the original Intel-based MacBooks came out. It was very exciting. I had never been a Mac user before. These computers are beautiful. They were so much fun. I wanted to have them, so I bought one personally. Then, when I switched jobs in 2008 and the company was run by a bunch of academics, all on Macs, I was like, "I will also take a Mac." Then I sat down on the first day, and I was like, "Oh, God. I can't run Project." That's when I started looking around for what are my options here, and I came across OmniPlan. I don't know. I mean, if you can fall in love with a piece of project management software, I think I fell in then because it was everything I wanted out of Project but was a much prettier interface. I could work on the laptop that I wanted to. It just became an easy, natural changeover from Project. I've been using it over since.
The dissent in Omnicare fervently advocated for a narrow interpretation of the majority holding, and most academics and practitioners, who thereafter commented on the decision agreed. Although never readdressed by the Delaware Supreme Court, more recent Court of Chancery decisions have lead many to question the continued vitality of Omnicare. This view emerged, in particular, after a transcript ruling in Optima Int'l of Miami, Inc. v. WCI Steel, Inc., C.A. No. 3833-VCL (Del. Ch. June 27, 2008) (Optima), where then Vice Chancellor Lamb approved a merger in which directors signed the merger agreement and stockholders approved the merger by written consent the next day. Thus, the transaction at issue in Optima did not involve circumstances similar to those in Omnicare, in which there was a significant period of time between board approval and the stockholder vote where the board was powerless to terminate the transaction prior to the stockholder vote, or to give stockholders a meaningful opportunity to vote against the transaction after a change of board recommendation, once a superior proposal emerged. The court distinguished stockholder approval by written consent from the lock-up present in Omnicare and explained that nothing in the Delaware General Corporation Law (DGCL) mandates a particular time between the board's authorization of a merger agreement and the subsequent stockholder approval. Notably, the court found the fact that the Optima merger agreement permitted termination of the transaction if the requisite consents were not obtained to be an important factor in its decision. With that in mind, the court upheld the stockholder approval by written consent and stated that the stockholders acted in accordance with the statute by submitting their consents after the board signed the merger agreement.
The future of retail is very exciting. As the forces of technology, competition, and new business models shape the retail landscape, pivotal questions are on the minds of all participants in the industry, including investors, entrepreneurs, business professionals, and academics. 2ff7e9595c
Comments